Antimicrobial Agents Practice Questions

Q: Which of the following drugs is NOT indicated in MRSA infection?

Imipenem. ### Explanation **Correct Option: D. Imipenem** **Why Imipenem is the correct answer:** Methicillin-resistant *Staphylococcus aureus* (MRSA) is defined by its resistance to almost all **$eta$-lactam antibiotics** (penicillins, cephalosporins, and carbapenems). This resistance is mediated by the **mecA gene**, which encodes an altered **Penicillin-Binding Protein (PBP2a)**. Standard $eta$-lactams, including **Imipenem** (a carbapenem), have a low affinity for PBP2a and therefore cannot inhibit cell wall synthesis in MRSA. *Note: The only $eta$-lactams effective against MRSA are the 5th generation cephalosporins (e.g., Ceftaroline, Ceftobiprole).* **Why the other options are incorrect:** * **A & B (Vancomycin & Teicoplanin):** These are Glycopeptides. They inhibit cell wall synthesis by binding to the D-Ala-D-Ala terminus of nascent peptidoglycan. They do not rely on PBPs for their action, making them the traditional "gold standard" for MRSA [2]. * **C (Linezolid):** This is an Oxazolidinone that inhibits protein synthesis (50S subunit). It is highly effective against MRSA and is particularly useful for MRSA-induced pneumonia due to its excellent lung penetration [1]. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice (DOC):** Vancomycin remains the DOC for systemic MRSA infections [2]. * **Alternative for VRSA:** If a strain is resistant to Vancomycin (VRSA), **Linezolid** or **Daptomycin** are used [1], [2]. * **Daptomycin Caution:** Never use Daptomycin for MRSA pneumonia because it is inactivated by pulmonary surfactant. * **Rapid Screening:** Cefoxitin disk diffusion is the preferred method to detect MRSA in the lab.

Q: Which drug is more potent and less toxic against herpes viruses?

Acyclovir. **Explanation:** **Acyclovir** is the correct answer because of its unique **selective toxicity** mechanism. It is a guanosine analogue that acts as a "prodrug." Its activation requires a viral-specific enzyme, **Thymidine Kinase (TK)**, to convert it into acyclovir monophosphate. Since host cells lack this viral TK, the drug remains inactive in non-infected cells. It is then further phosphorylated by host cell kinases to acyclovir triphosphate, which causes DNA chain termination by inhibiting viral DNA polymerase. This high selectivity makes it highly potent against HSV-1, HSV-2, and VZV while remaining remarkably non-toxic to human cells. **Analysis of Incorrect Options:** * **Zidovudine (AZT):** A Nucleoside Reverse Transcriptase Inhibitor (NRTI) used primarily for **HIV**. While it also causes chain termination, it is not the drug of choice for Herpes and carries significant toxicity (e.g., bone marrow suppression). * **Nystatin:** A polyene **antifungal** agent used for *Candida* infections. It works by binding to ergosterol in fungal cell membranes and has no activity against viruses. * **Amantadine:** An **anti-influenza** drug (and anti-Parkinsonian agent) that inhibits the M2 protein ion channel. It is ineffective against the Herpesviridae family. **High-Yield Clinical Pearls for NEET-PG:** * **Resistance:** Most common cause of Acyclovir resistance is the absence or mutation of viral **Thymidine Kinase**. * **Drug of Choice:** Acyclovir is the DOC for Herpes Simplex Encephalitis and Genital Herpes. * **Valacyclovir:** A prodrug of acyclovir with much higher oral bioavailability (used to improve dosing compliance). * **Side Effect:** Rapid IV infusion can cause **crystalline nephropathy**; ensure adequate hydration.

Q: Red urine without RBCs is seen in which of the following conditions?

Following Rifampicin ingestion. ### Explanation The presence of red urine without red blood cells (RBCs) on microscopy is a classic clinical finding that distinguishes **discoloration (pseudohematuria)** from true hematuria. **1. Why Option D is Correct:** **Rifampicin**, a key bactericidal drug used in Tuberculosis (RNTCP/NTEP), is a highly lipid-soluble, macrocyclic antibiotic. It is excreted through bile and urine. A unique characteristic of Rifampicin is its ability to cause a **harmless, reddish-orange discoloration** of all body secretions, including urine, sweat, saliva, and tears. Since this is due to the pigment of the drug itself and not due to bleeding, microscopy will show **zero RBCs**. **2. Why Incorrect Options are Wrong:** * **Lupus Nephritis (A):** This is an inflammatory glomerulonephritis. It typically presents with **microscopic or macroscopic hematuria**, meaning RBCs (often dysmorphic) will be present in the urine. * **Pyelonephritis (B):** This is an upper urinary tract infection. It is characterized by pyuria (WBCs) and frequently involves **hematuria** due to mucosal inflammation. * **Hemolytic Uremic Syndrome (C):** HUS involves microangiopathic hemolytic anemia and acute kidney injury. It typically presents with **hematuria** and hemoglobinuria. **3. High-Yield Clinical Pearls for NEET-PG:** * **Other causes of red urine without RBCs:** Myoglobinuria (rhabdomyolysis), Hemoglobinuria (intravascular hemolysis), and ingestion of Beetroot (Beeturia) or Senna. * **Rifampicin Counseling:** Always counsel patients that orange-red urine is a side effect, not a sign of toxicity, to ensure treatment adherence. * **Mechanism of Rifampicin:** Inhibits DNA-dependent RNA polymerase. * **Drug Interactions:** Rifampicin is a potent **Cytochrome P450 inducer**, leading to decreased plasma levels of drugs like Warfarin and Oral Contraceptive Pills (OCPs).

Q: What is the role of ethambutol in the Revised National Tuberculosis Control Programme (RNTCP) regimen?

Bacteriostatic and detrimental to fast multiplying bacilli. ### Explanation **1. Why the Correct Answer is Right:** Ethambutol is a **bacteriostatic** antitubercular drug. Its primary mechanism of action involves the inhibition of the enzyme **arabinosyl transferase**, which is essential for the synthesis of arabinogalactan (a critical component of the mycobacterial cell wall). Since cell wall synthesis occurs most actively during cell division, ethambutol is most effective against **fast-multiplying bacilli** (extracellular bacteria). By inhibiting wall synthesis, it prevents the multiplication of the bacteria rather than killing them directly. **2. Why the Other Options are Wrong:** * **Options A & B (Bactericidal):** Ethambutol is the only primary antitubercular drug that is bacteriostatic at standard therapeutic doses. Drugs like Isoniazid, Rifampicin, and Pyrazinamide are bactericidal. * **Options B & D (Dormant/Slow multiplying):** Ethambutol has no significant activity against dormant (latent) or slow-multiplying (intracellular) bacilli. **Pyrazinamide** is the drug of choice for acidic environments (intracellular/slow-multiplying), while **Rifampicin** is highly effective against spurters (semidormant bacilli). **3. NEET-PG High-Yield Clinical Pearls:** * **Visual Side Effects:** The most characteristic side effect is **Retrobulbar Neuritis**, leading to decreased visual acuity, central scotoma, and **red-green color blindness**. It is generally dose-dependent and reversible. * **Contraindication:** It should be avoided in children below 6 years of age because they cannot reliably report changes in visual acuity or color perception. * **Uric Acid:** Like Pyrazinamide, Ethambutol can decrease the excretion of uric acid, potentially leading to **hyperuricemia**. * **Role in RNTCP:** Its primary role in the Intensive Phase (2HRZE) is to prevent the emergence of resistance to more potent drugs like Isoniazid and Rifampicin.

Q: A person on anti-tubercular drugs complained of deafness and tinnitus in one ear. Which drug is most likely implicated?

Streptomycin. **Explanation:** The correct answer is **Streptomycin**. **1. Why Streptomycin is correct:** Streptomycin is an **Aminoglycoside** antibiotic used as a first-line injectable drug in the treatment of Tuberculosis. The hallmark toxicity of aminoglycosides is **ototoxicity**, which occurs due to the destruction of sensory hair cells in the inner ear. Streptomycin specifically targets the **vestibulocochlear nerve (Cranial Nerve VIII)**. While it is more vestibulotoxic (causing vertigo and ataxia), it also causes permanent cochlear damage, leading to **tinnitus and sensorineural hearing loss (deafness)**. **2. Why the other options are incorrect:** * **Isoniazid (INH):** The most characteristic side effect is **peripheral neuropathy** (due to Vitamin B6 deficiency) and hepatotoxicity. It does not affect hearing. * **Ethambutol:** The classic adverse effect is **retrobulbar neuritis**, which manifests as decreased visual acuity and **red-green color blindness**. It is not ototoxic. * **Rifampicin:** Known for causing **orange-colored discoloration** of body fluids (urine, sweat, tears) and hepatotoxicity. It does not cause deafness. **Clinical Pearls for NEET-PG:** * **Ototoxicity:** Streptomycin is more vestibulotoxic, whereas Amikacin and Kanamycin are more cochleotoxic. * **Pregnancy:** Streptomycin is **contraindicated in pregnancy** because it can cross the placenta and cause congenital deafness in the fetus. * **Renal Monitoring:** Since aminoglycosides are excreted unchanged by the kidneys, dose adjustment is required in renal failure to prevent both ototoxicity and nephrotoxicity. * **Mnemonic for Ethambutol:** **E**thambutol for **E**ye (Optic neuritis).

Q: A female patient treated with antibiotics for chlamydia-induced UTI presents with itching/pruritus, vaginal discharge, and burning micturition. Which drug should be given?

Azithromycin. ### **Explanation** **Correct Option: B. Azithromycin** The clinical scenario describes a patient with a **Chlamydial urinary tract infection (UTI)/Urethritis**. *Chlamydia trachomatis* is an obligate intracellular pathogen. **Azithromycin**, a macrolide, is the drug of choice because it achieves high intracellular concentrations and has a long half-life, allowing for a **single-dose (1g)** curative regimen. This ensures high patient compliance compared to multi-day courses. **Analysis of Incorrect Options:** * **A. Ceftriaxone:** This is a third-generation cephalosporin used primarily for *Neisseria gonorrhoeae*. While Chlamydia and Gonorrhea often co-infect, Ceftriaxone is ineffective against Chlamydia because the organism lacks a typical peptidoglycan cell wall (the target of beta-lactams). * **C. Moxifloxacin:** While some fluoroquinolones (like Ofloxacin or Levofloxacin) can treat Chlamydia, they are second-line agents. Moxifloxacin is generally reserved for respiratory infections or resistant Pelvic Inflammatory Disease (PID) and is not the primary choice for uncomplicated Chlamydial UTI. * **D. Amphotericin B:** This is a potent antifungal used for systemic fungal infections (e.g., Mucormycosis). It has no activity against bacterial pathogens like Chlamydia. **NEET-PG High-Yield Pearls:** * **DOC for Chlamydia:** Azithromycin (1g stat) or Doxycycline (100mg BID for 7 days). * **Pregnancy:** Azithromycin is the preferred agent for Chlamydia in pregnant women (Doxycycline is contraindicated due to fetal bone/teeth effects). * **Syndromic Management (Green Kit):** Used for vaginal discharge; contains Fluconazole (for Candidiasis) and Azithromycin (for Chlamydia). * **Reiter’s Syndrome:** A classic triad of "Can't see, can't pee, can't climb a tree" (Uveitis, Urethritis, Arthritis) often triggered by a Chlamydia infection.

Q: Which of the following is a fifth-generation cephalosporin?

Ceftaroline. **Explanation:** **Ceftaroline** is the correct answer as it is a member of the **fifth-generation cephalosporins**. The defining clinical characteristic of this generation is its unique ability to bind to **PBP-2a**, an altered penicillin-binding protein that confers resistance in Staphylococci. This makes fifth-generation agents the only cephalosporins effective against **Methicillin-resistant *Staphylococcus aureus* (MRSA)**. **Analysis of Incorrect Options:** * **Cefepime (Option A):** This is a **fourth-generation** cephalosporin. It is a "zwitterion" that can rapidly penetrate the outer membrane of Gram-negative bacteria. It is highly effective against *Pseudomonas aeruginosa* but lacks activity against MRSA. * **Cefpirome (Option C):** Also a **fourth-generation** cephalosporin, similar in spectrum to Cefepime, primarily used for life-threatening nosocomial infections. * **Cefprozil (Option D):** This is a **second-generation** oral cephalosporin used mainly for respiratory tract infections and skin/soft tissue infections. **High-Yield Clinical Pearls for NEET-PG:** * **Fifth-Generation Agents:** Include **Ceftaroline** and **Ceftobiprole**. * **MRSA Coverage:** Remember the mnemonic: "Ceftaroline covers the 'Staph' that others can't." * **VRSA & VISA:** Ceftaroline also shows activity against Vancomycin-resistant and Vancomycin-intermediate *S. aureus*. * **LAME Mnemonic:** Cephalosporins generally do **NOT** cover **L**isteria, **A**typicals (Mycoplasma/Chlamydia), **M**RSA (except 5th gen), and **E**nterococci (except Ceftaroline/Ceftobiprole which have some Enterococcal activity). * **Excretion:** Most cephalosporins are renally excreted; **Ceftriaxone** is a notable exception (biliary excretion), requiring no dose adjustment in renal failure.

Q: What is the mechanism of action of Oseltamivir and Zanamivir?

Neuraminidase inhibition. **Mechanism of Action: Neuraminidase Inhibitors** **Correct Answer: D. Neuraminidase inhibition** Oseltamivir and Zanamivir are structural analogs of sialic acid. Their primary mechanism involves the competitive inhibition of **Neuraminidase (NA)**, an enzyme found on the surface of Influenza A and B viruses. * **The Concept:** During the viral life cycle, new virions bud from the host cell membrane but remain attached via hemagglutinin to sialic acid receptors. Neuraminidase cleaves these receptors, allowing the release of progeny virions. By inhibiting this enzyme, Oseltamivir and Zanamivir cause the newly formed viruses to clump together and remain stuck to the host cell, thereby preventing the infection of new cells. **Why other options are incorrect:** * **A & B (DNA polymerase/mRNA inhibition):** These are mechanisms typical of anti-herpetic drugs (e.g., Acyclovir) or certain RNA polymerase inhibitors (e.g., Ribavirin). Influenza is an RNA virus, and these drugs do not target its genetic replication directly. * **C (Blocking viral uncoating):** This is the mechanism of **Amantadine and Rimantadine**, which inhibit the **M2 ion channel** [3]. These drugs are now largely obsolete due to widespread resistance. **High-Yield Clinical Pearls for NEET-PG:** * **Timing:** These drugs are most effective when started within **48 hours** of symptom onset [1], [2]. * **Routes:** Oseltamivir is **oral** (prodrug) [2], while Zanamivir is **inhaled** (contraindicated in asthma/COPD due to risk of bronchospasm). * **Peramivir:** An intravenous neuraminidase inhibitor used for acute uncomplicated influenza. * **Baloxavir Marboxil:** A newer agent that inhibits **cap-dependent endonuclease**, blocking viral mRNA synthesis (a frequent "next-step" question).

Question 1

Which of the following drugs is NOT indicated in MRSA infection?

Accepted Answer

Imipenem

Answer

Vancomycin

Answer

Teicoplanin

Answer

Linezolid

Question 2

Which drug is more potent and less toxic against herpes viruses?

Accepted Answer

Acyclovir

Answer

Zidovudine

Answer

Nystatin

Answer

Amantidine

Question 3

Which drugs are recommended by WHO for Artemisinin-based combination therapy?

Accepted Answer

Dihydroartemisinin plus piperaquine

Answer

Atremether plus proguanil

Answer

Artesunate plus doxycycline

Answer

Artesunate plus piperaquine

Question 4

Red urine without RBCs is seen in which of the following conditions?

Accepted Answer

Following Rifampicin ingestion

Answer

Lupus nephritis

Answer

Pyelonephritis

Answer

Hemolytic uremic syndrome

Question 5

What is the role of ethambutol in the Revised National Tuberculosis Control Programme (RNTCP) regimen?

Accepted Answer

Bacteriostatic and detrimental to fast multiplying bacilli

Answer

Bactericidal and detrimental to semidormant bacilli

Answer

Bactericidal and detrimental to dormant bacilli

Answer

Bacteriostatic and detrimental to slow multiplying bacilli

Question 6

A person on anti-tubercular drugs complained of deafness and tinnitus in one ear. Which drug is most likely implicated?

Accepted Answer

Streptomycin

Answer

Isoniazid

Answer

Ethambutol

Answer

Rifampicin

Question 7

Efavirenz limits HIV infection by:

Accepted Answer

Serving as an allosteric inhibitor of HIV reverse transcriptase

Answer

Binding to the active site of HIV reverse transcriptase

Answer

Impairing the binding of HIV virion to CD4 receptors on T-cells

Answer

Inhibiting the HIV protease

Question 8

A female patient treated with antibiotics for chlamydia-induced UTI presents with itching/pruritus, vaginal discharge, and burning micturition. Which drug should be given?

Accepted Answer

Azithromycin

Answer

Ceftriaxone

Answer

Moxifloxacin

Answer

Amphotericin B

Question 9

Which of the following is a fifth-generation cephalosporin?

Accepted Answer

Ceftaroline

Answer

Cefepime

Answer

Cefpirome

Answer

Cefprozil

Question 10

What is the mechanism of action of Oseltamivir and Zanamivir?

Accepted Answer

Neuraminidase inhibition

Answer

DNA polymerase inhibition

Answer

Inhibition of viral mRNA

Answer

Blocking viral uncoating

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?